SPARK Denmark Alumnus Launches Akasi Pharma to Tackle Neuropathic Pain Without Opioids
Posted on April 1st, 2025
We congratulate Walden Bjørn-Yoshimoto who was enrolled in the first cohort in the Danish SPARK programme in 2023 and has established a biotech company, Akasi Pharma in 2025. The company is focusing on new non-opioid treatments for neuropathic pain. Akasi Pharma has established funding from the Danish Biotech incubator BioInnovation Institute.
Permalink: https://sparkglobal.io/spark-denmark-alumnus-launches-akasi-pharma-to-tackle-neuropathic-pain-without-opioids/